Can semaglutide (glucagon-like peptide-1 receptor agonist) cause dry mouth?

Semaglutide and Dry Mouth

Yes, semaglutide can cause dry mouth (xerostomia) as evidenced by recent case reports documenting this side effect in patients using the medication for weight loss. 1

Evidence for Semaglutide-Associated Dry Mouth

• Recent case reports have documented hyposalivation (reduced saliva production) in patients using semaglutide, with patients developing secondary xerostomia after starting the medication 1
• While dry mouth is not specifically listed among the most common side effects in the FDA label for semaglutide, it falls within the category of "other adverse reactions" that occur with the medication 2
• Dry mouth (xerostomia) is documented as a common side effect of other GLP-1 receptor agonists in the same class as semaglutide 3

Mechanism of Dry Mouth with GLP-1 Receptor Agonists

• GLP-1 receptors are found throughout the body, including in the central nervous system and autonomic nervous system, which may contribute to various side effects including dry mouth 3, 4
• The effect on salivary gland function may be related to semaglutide's action on the autonomic nervous system, as GLP-1 receptor agonists are known to affect vagal nervous activity 4
• GLP-1 receptor agonists like semaglutide affect multiple organ systems, which explains their diverse side effect profile 3, 4

Common Side Effects of Semaglutide

• The most frequently reported adverse effects of semaglutide are gastrointestinal, including:
  • Nausea and vomiting 3, 5
  • Diarrhea 3, 5
  • Constipation 5
  • Gastrointestinal reflux 3, 5
• Other documented side effects include:
  • Injection site reactions (for injectable formulations) 2
  • Fatigue, dysgeusia (altered taste), and dizziness 2
  • Increases in heart rate (2-3 beats per minute) 2

Management of Dry Mouth with Semaglutide

• Gradual dose titration of semaglutide may help mitigate side effects, including dry mouth 4, 5
• For patients experiencing significant dry mouth symptoms, management options include:
  • Ensuring adequate hydration 4
  • Using saliva substitutes or oral moisturizers 1
  • In severe cases, considering medications that stimulate saliva production (e.g., pilocarpine) 1
  • Dose reduction if symptoms are severe and affecting quality of life 4, 5

Clinical Implications of Dry Mouth

• Dry mouth can lead to:
  • Increased risk of dental caries and periodontal disease 6
  • Oral discomfort and difficulty speaking or swallowing 6
  • Altered taste perception 6
• The risk of xerostomia increases when multiple medications with this side effect are taken concurrently 6

Monitoring and Follow-up

• Monitor for dry mouth symptoms, especially during the initial titration phase of semaglutide 4, 5
• Follow up within 2-4 weeks after starting semaglutide to assess for side effects including dry mouth 4
• Document response to interventions and adjust management accordingly 4

While dry mouth is not among the most commonly reported side effects in clinical trials of semaglutide, emerging case reports suggest it can occur in some patients. Healthcare providers should be aware of this potential side effect and be prepared to manage it appropriately to improve patient comfort and medication adherence.